ClinicalTrials.gg
CompletedNCT06359028Updated Jun 24, 2025Results posted

Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

An interventional study of Stannous fluoride toothpaste and Crest cavity protection toothpaste in Dentin Sensitivity, sponsored by HALEON. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-24.

Sponsored by HALEON · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 21 studies in Dentin Sensitivity by HALEON — 3 open to participants now, 4 under way, none of them phase 3. Dentin Sensitivity · HALEON.

Enrollment
17th of 20
111 · median 185
Started
2024
with 3 others
No phase
18 of 21
2 open now
Registered
7th of 21
by date

Among the 21 studies in Dentin Sensitivity by HALEON, this one is the 17th largest by enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2024, is one of 18 with no phase, and was the 7th registered.

Dentin Sensitivity

290 studies on the registry are indexed under Dentin Sensitivity; 47 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

3 of the 21 studies in Dentin Sensitivity by HALEON are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 18 Dentin Sensitivity studies recruiting now, 6 (33%) set no upper age limit and 11 (61%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Dentin Sensitivity by HALEON, or all of them as a file.
02

Study summary

The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.

Read the detailed description

This will be a single center, 8-week, randomized, controlled, examiner-blind, 2-treatment arm, parallel design, stratified (by maximum baseline Schiff sensitivity score of the two selected 'test teeth') clinical study to evaluate the anti-sensitivity efficacy of a 0.454% SnF2 toothpaste in a DH population. The clinical efficacy of the 0.454% SnF2 toothpaste (test toothpaste) will be compared with that of a reference toothpaste, a commercially available, regular fluoride toothpaste with no known anti-sensitivity properties (negative control). Sufficient participants will be screened to randomize approximately 110 participants to investigational product (approximately 55 per treatment group) and to ensure approximately 100 evaluable participants complete the entire study (approximately 50 per treatment group).

03

Conditions studied

  • Dentin Sensitivity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant provision of signed and dated before any study procedures are performed.
  • Participant is male or female.
  • Participant is 18 to 65 years of age, inclusive, at the time of signing the informed consent.
  • Participant is willing and able to comply with the study visit schedule, product usage instructions, lifestyle restrictions and other study procedures.
  • Participant is in good general, oral and mental health with, in the opinion of the investigator or medically qualified designee, no or relevant abnormalities in self-reported medical history, or upon oral examination, that would impact their safety or wellbeing, or the outcomes of the study, if they were to participate in the study, or affect their ability to understand and follow study requirements.
  • Screening (Visit 1): Participant must have-

    1. History of tooth sensitivity lasting more than six months but not more than 10 years (self-reported).
    2. Good general oral health, with a minimum of 20 natural teeth.
    3. Minimum of 2 accessible, non-adjacent teeth (incisors, canines, premolars), in different quadrants, which meet all of the following criteria:

      1. Exposed dentin due to facial/cervical erosion, abrasion or gingival recession (EAR).
      2. Modified Gingival Index (MGI) = 0 directly adjacent to the exposed dentin (that is, the test area only).
      3. Clinical mobility = 0
      4. Clinically confirmed DH to both tactile and evaporative (air) stimuli: a) Qualifying tactile threshold less than or equal to (\<=) 20g. b) Qualifying Schiff sensitivity score more than or equal to (>=) 2.
  • Baseline (Visit 2, Pre-Treatment)

    1. Participant must have a minimum of two, non-adjacent accessible teeth (incisors, canines, premolars), in different quadrants, with clinically confirmed DH to both tactile and evaporative (air) stimuli at both screening (Visit 1) and baseline (Visit 2).

      1. Qualifying tactile threshold \<= 20g at screening and baseline.
      2. Qualifying Schiff sensitivity score >= 2 at screening and baseline.
    2. The clinical examiner will select two 'Test Teeth' from those which meet the tactile threshold and Schiff sensitivity score inclusion criteria at both screening and baseline. Notes: All teeth with clinically confirmed, qualifying levels of DH at screening (that is, a screening tactile threshold \<= 20 g and a screening Schiff sensitivity score >= 2) will be assessed for tactile sensitivity at baseline. Teeth with a baseline tactile threshold \<= 20g will then be assessed for baseline evaporative (air) sensitivity.

Exclusion criteria

Exclusion Criteria:

  • Participant is an employee of the investigator site directly involved in the conduct of the study, or an employee of the investigator site otherwise supervised by the investigator, or a member of their immediate family.
  • Participant is an employee of the sponsor directly involved in the conduct of the study or a member of their immediate family.
  • Female participant who is pregnant or intending to become pregnant during the study (self-reported).
  • Female participant who is breastfeeding (self-reported).
  • Participant with known or suspected intolerance or to the study products, any of their stated ingredients or closely related compounds (self-reported).
  • Participant with a recent history (within the last year) of alcohol or other substance abuse (self-reported).
  • Participant is participating in or has participated in other studies (including non-medicinal studies) involving product(s) within 30 days of screening (Visit 1) or plans to participate in other studies (including non-medicinal studies) during this study.
  • Participant has participated in a tooth sensitivity study within 8 weeks of screening (Visit 1).
  • Participant is currently using an oral care product indicated for DH relief or care of sensitive teeth or has used an anti-sensitivity product within 8 weeks of screening (Visit 1). Participants will be required to bring their current oral care products to screening (Visit 1) for staff to verify the absence of known anti-sensitivity ingredients and sensitivity-related claims on the product packaging/label text.
  • Participant takes daily doses of medications/treatments which, in the opinion of the investigator or medically qualified designee, could interfere with their perception of tooth sensitivity (for example, analgesics, anticonvulsants, antihistamines that cause marked or moderate sedation, sedatives, tranquilizers, antidepressants, mood-altering and anti-inflammatory drugs).
  • Screening (Visit 1): Participant has taken antibiotics in the 2 weeks prior to screening (Visit 1).
  • Baseline (Visit 2, Pre-Treatment): Participant has taken antibiotics in the 2 weeks prior to baseline (Visit 2), that is, during the acclimatization period.
  • Participant takes daily doses of a medication which, in the opinion of the investigator or medically qualified designee, is causing xerostomia.
  • Participant requires antibiotic prophylaxis for dental procedures.
  • Participant has had professional tooth de-sensitising treatment within 8 weeks of screening (Visit 1).
  • Participant has had a tooth bleaching procedure within 8 weeks of screening (Visit 1).
  • Participant has had dental prophylaxis within 4 weeks of screening (Visit 1).
  • Participant has had treatment for periodontal disease (including surgery) within 12 months of screening (Visit 1).
  • Participant has had scaling or root planning within 3 months of screening (Visit 1).
  • Participant with gross periodontal disease.
  • Participant with a tongue or lip piercing.
  • Participant with evidence of gross intra-oral neglect or the need for extensive dental therapy.
  • Participant with a fixed or removable partial prosthesis which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes.
  • Participant with multiple dental implants which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes.
  • Participant with fixed or removable orthodontic braces/bands or a fixed orthodontic retainer.
  • Specific dentition exclusions for 'Test Teeth':

    1. Tooth with evidence of current/recent caries.
    2. Tooth with (self-reported) treatment for decay within 12 months of screening (Visit 1).
    3. Tooth with exposed dentin and deep, defective or facial restorations.
    4. Tooth with a full crown or veneer.
    5. Tooth adjacent to a bridge abutment or crown which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes.
    6. Sensitive tooth with contributing etiologies other than EAR to exposed dentin.
    7. Sensitive tooth not expected to benefit from use of an anti-sensitivity toothpaste, in the opinion of the investigator or dentally qualified designee.
  • Participant who, in the opinion of the investigator or designee, is unable to provide appropriate responses to the Labelled Magnitude Scale (LMS) training questions.
  • Participant has previously been enrolled in this study.
  • Participant who, in the opinion of the investigator or medically qualified designee, should not participate in the study.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
111 participants (actual)

Study arms

  • Experimental
    Test toothpaste

    Participants will dose the toothbrush with a ribbon of toothpaste, across the full brush head and will brush the entire dentition thoroughly for at least 1-timed minute, twice daily (morning and evening), for approximately 56 days making sure to brush the sensitive areas of the two 'test teeth' carefully first. Participants who wish to rinse after brushing will be instructed to rinse with 10 milliliter (ml) water using graduated rinsing cup provided.

    Drug: Stannous fluoride toothpaste

  • Active comparator
    Reference toothpaste (Negative control)

    Participants will dose the toothbrush with a ribbon of toothpaste, across the full brush head and will brush the entire dentition thoroughly for at least 1-timed minute, twice daily (morning and evening) for approximately 56 days. Participants who wish to rinse after brushing will be instructed to rinse with 10 ml water using graduated rinsing cup provided.

    Drug: Crest cavity protection toothpaste

Interventions

  • Toothpaste containing 0.454 % weight/weight (w/w) SnF2

  • DrugCrest cavity protection toothpaste

    Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.

06

What researchers measure

Primary outcomes

  1. Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 56

    Schiff sensitivity score was assessed by participant's response to an evaporative (air) stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. Participant's response to the stimulus was evaluated by the examiner using the Schiff sensitivity scale immediately following administration of the evaporative air stimulus. Score ranged from 0-3, where 0=Does not respond to air stimulation; 1=Responds to air stimulus but does not request discontinuation of stimulus; 2=Responds to air stimulus and requests discontinuation or moves from stimulus; 3=Responds to stimulus, considers stimulus to be painful, requests discontinuation of the stimulus. Schiff sensitivity score = Mean score for the two 'Test Teeth' selected at baseline by the examiner. Change from baseline was calculated by subtracting baseline score from Day 56 score. A decrease in Schiff sensitivity score indicated an improvement.

    Time frame: Baseline and Day 56

Secondary outcomes

  1. Adjusted Mean Change From Baseline in Tactile Threshold at Day 56

    Tactile sensitivity was assessed by participant's response to tactile stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. A constant pressure probe (Yeaple probe) was used for stimulation. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine. After each application, the participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold in gram (g). At baseline, the upper force setting was 20g. Tactile threshold (g) was derived as the mean value for the two 'Test Teeth' selected by the examiner at baseline. An increase in tactile threshold indicated an improvement in sensitivity. Change from baseline was calculated by subtracting baseline value from Day 56 value.

    Time frame: Baseline and Day 56

  2. Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 28

    Schiff sensitivity score was assessed by participant's response to an evaporative (air) stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. Participant's response to the stimulus was evaluated by the examiner using the Schiff sensitivity scale immediately following administration of the evaporative air stimulus. Score ranged from 0-3, where 0=Does not respond to air stimulation; 1=Responds to air stimulus but does not request discontinuation of stimulus; 2=Responds to air stimulus and requests discontinuation or moves from stimulus; 3=Responds to stimulus, considers stimulus to be painful, requests discontinuation of the stimulus. Schiff sensitivity score = Mean score for the two 'Test Teeth' selected at baseline by the examiner. Change from baseline was calculated by subtracting baseline score from Day 28 score. A decrease in Schiff sensitivity score indicated an improvement.

    Time frame: Baseline and Day 28

  3. Adjusted Mean Change From Baseline in Tactile Threshold at Day 28

    Tactile sensitivity was assessed by participant's response to tactile stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. A constant pressure probe (Yeaple probe) was used for stimulation. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine. After each application, the participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold in gram. At baseline, the upper force setting was 20g. Tactile threshold (g) was derived as the mean value for the two 'Test Teeth' selected by the examiner at baseline. An increase in tactile threshold indicated an improvement in sensitivity. Change from baseline was calculated by subtracting baseline value from Day 28 value.

    Time frame: Baseline and Day 28

  4. Adjusted Mean Change From Baseline in Impact on Everyday Life (Section 1 of Dentin Hypersensitivity Experience Questionnaire [DHEQ-48], Question [Q]7-9) at Days 28 and 56

    DHEQ section 1, questions 7-9 were about teeth sensation and its impact on everyday life. Participants scored Q7 (how intense are the sensations?) on a scale of 1 (not at all intense) to 10 (worst imaginable); Q8 (how bothered are you by any sensations?) on a scale of 1 (not at all bothered) to 10 (extremely bothered); Q9 (how well can you tolerate sensations?) on a scale of 1 (can easily tolerate) to 10 (can't tolerate at all). Thus, the total score ranged from 3 to 30; where the lower score indicated less sensitivity and less impact on everyday life. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  5. Adjusted Mean Change From Baseline in DHEQ Total Score (Section 2, Q1-34) at Days 28 and 56

    The DHEQ was a condition-specific measure of Oral Health-related Quality of Life (OHrQoL) in relation to DH which consisted of a total of 34 questions in section 2 grouped into 5 separate domains: Restrictions(Q1-4), Adaptation(Q5-16), Social Impact(Q17-21), Emotional Impact(Q22-29), and Identity(Q30-34), each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 34 to 238; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  6. Adjusted Mean Change From Baseline in DHEQ Restrictions Domain (Section 2, Q1-4) Score at Days 28 and 56

    Restrictions domain in DHEQ evaluated the ways in which any sensations in teeth affected participant's daily life. This consisted of 4 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 4 to 28; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  7. Adjusted Mean Change From Baseline in DHEQ Adaptation Domain Score (Section 2, Q5-16) at Days 28 and 56

    Adaptation domain in DHEQ evaluated 'the ways in which the sensations in teeth have forced participants to change things in their daily life'; 'things they do in their daily life to avoid experiencing the sensations in their teeth'. This consisted of 12 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 12 to 84; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  8. Adjusted Mean Change From Baseline in DHEQ Social Impact Domain (Section 2, Q17-21) Score at Days 28 and 56

    Social Impact domain in DHEQ evaluated the way the sensations affected participants when they were with other people or in certain situations. This consisted of 5 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 5 to 35; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  9. Adjusted Mean Change From Baseline in DHEQ Emotional Impact Domain (Section 2, Q22-29) Score at Days 28 and 56

    Emotional Impact Domain in DHEQ evaluated the way the sensations in participant's teeth made them feel. This consisted of 8 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 8 to 56; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  10. Adjusted Mean Change From Baseline in DHEQ Identity Domain (Section 2, Q30-34) Score at Days 28 and 56

    Identity Domain in DHEQ evaluated what the sensations in participant's teeth meant for them. This consisted of 5 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 5 to 35; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  11. Adjusted Mean Change From Baseline in Global Oral Health (DHEQ Section 2, Q35) Score at Days 28 and 56

    Global Oral Health was evaluated using a single question which asked about the overall health of participant's mouth, teeth, and gums. The scale ranged from 1 (excellent) to 6 (Very poor), where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

  12. Adjusted Mean Change From Baseline in Effect on Life Overall (DHEQ Section 2, Q36-39) Score at Days 28 and 56

    Effect on life was evaluated using 4 questions which asked how much the sensations in teeth affected participant's life overall. The scale ranged from 0 (not at all) to 4 (Very much) and thus, the total score ranged from 0 to 16; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoint minus score at baseline.

    Time frame: Baseline, Day 28 and Day 56

07

Results

Posted Jun 24, 2025

Participant flow

This study was conducted at a single center in the United States.

Participant flow — Overall Study
MilestoneTest ToothpasteReference Toothpaste (Negative Control)
Started5351
Completed5151
Not completed20
Withdrew: Adverse event10
Withdrew: Withdrawal by subject10

Outcome measures

PrimaryAdjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 56

Schiff sensitivity score was assessed by participant's response to an evaporative (air) stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. Participant's response to the stimulus was evaluated by the examiner using the Schiff sensitivity scale immediately following administration of the evaporative air stimulus. Score ranged from 0-3, where 0=Does not respond to air stimulation; 1=Responds to air stimulus but does not request discontinuation of stimulus; 2=Responds to air stimulus and requests discontinuation or moves from stimulus; 3=Responds to stimulus, considers stimulus to be painful, requests discontinuation of the stimulus. Schiff sensitivity score = Mean score for the two 'Test Teeth' selected at baseline by the examiner. Change from baseline was calculated by subtracting baseline score from Day 56 score. A decrease in Schiff sensitivity score indicated an improvement.

Time frame:
Baseline and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 56-2.25 ± 0.080-0.31 ± 0.080
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: -1.94 · 95% CI -2.16 to -1.72
SecondaryAdjusted Mean Change From Baseline in Tactile Threshold at Day 56

Tactile sensitivity was assessed by participant's response to tactile stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. A constant pressure probe (Yeaple probe) was used for stimulation. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine. After each application, the participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold in gram (g). At baseline, the upper force setting was 20g. Tactile threshold (g) was derived as the mean value for the two 'Test Teeth' selected by the examiner at baseline. An increase in tactile threshold indicated an improvement in sensitivity. Change from baseline was calculated by subtracting baseline value from Day 56 value.

Time frame:
Baseline and Day 56
Reported as:
Least squares mean · gram
Adjusted Mean Change From Baseline in Tactile Threshold at Day 56
gramTest ToothpasteReference Toothpaste (Negative Control)
Adjusted Mean Change From Baseline in Tactile Threshold at Day 5660.07 ± 2.5392.70 ± 2.544
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: 57.37 · 95% CI 50.23 to 64.51
SecondaryAdjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 28

Schiff sensitivity score was assessed by participant's response to an evaporative (air) stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. Participant's response to the stimulus was evaluated by the examiner using the Schiff sensitivity scale immediately following administration of the evaporative air stimulus. Score ranged from 0-3, where 0=Does not respond to air stimulation; 1=Responds to air stimulus but does not request discontinuation of stimulus; 2=Responds to air stimulus and requests discontinuation or moves from stimulus; 3=Responds to stimulus, considers stimulus to be painful, requests discontinuation of the stimulus. Schiff sensitivity score = Mean score for the two 'Test Teeth' selected at baseline by the examiner. Change from baseline was calculated by subtracting baseline score from Day 28 score. A decrease in Schiff sensitivity score indicated an improvement.

Time frame:
Baseline and Day 28
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 28
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Day 28-1.75 ± 0.085-0.10 ± 0.086
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: -1.65 · 95% CI -1.89 to -1.41
SecondaryAdjusted Mean Change From Baseline in Tactile Threshold at Day 28

Tactile sensitivity was assessed by participant's response to tactile stimulus after the stimulation of the 2 test teeth selected at Baseline by the examiner. A constant pressure probe (Yeaple probe) was used for stimulation. The probe tip was placed perpendicular to the facial surface of tooth and drawn slowly across the exposed dentine. After each application, the participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold in gram. At baseline, the upper force setting was 20g. Tactile threshold (g) was derived as the mean value for the two 'Test Teeth' selected by the examiner at baseline. An increase in tactile threshold indicated an improvement in sensitivity. Change from baseline was calculated by subtracting baseline value from Day 28 value.

Time frame:
Baseline and Day 28
Reported as:
Least squares mean · gram
Adjusted Mean Change From Baseline in Tactile Threshold at Day 28
gramTest ToothpasteReference Toothpaste (Negative Control)
Adjusted Mean Change From Baseline in Tactile Threshold at Day 2836.59 ± 3.0091.23 ± 3.038
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: 35.37 · 95% CI 26.88 to 43.86
SecondaryAdjusted Mean Change From Baseline in Impact on Everyday Life (Section 1 of Dentin Hypersensitivity Experience Questionnaire [DHEQ-48], Question [Q]7-9) at Days 28 and 56

DHEQ section 1, questions 7-9 were about teeth sensation and its impact on everyday life. Participants scored Q7 (how intense are the sensations?) on a scale of 1 (not at all intense) to 10 (worst imaginable); Q8 (how bothered are you by any sensations?) on a scale of 1 (not at all bothered) to 10 (extremely bothered); Q9 (how well can you tolerate sensations?) on a scale of 1 (can easily tolerate) to 10 (can't tolerate at all). Thus, the total score ranged from 3 to 30; where the lower score indicated less sensitivity and less impact on everyday life. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Impact on Everyday Life (Section 1 of Dentin Hypersensitivity Experience Questionnaire [DHEQ-48], Question [Q]7-9) at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Q7, Day 28-1.44 ± 0.216-0.61 ± 0.199
Q7, Day 56-2.83 ± 0.217-0.71 ± 0.225
Q8, Day 28-1.69 ± 0.224-0.53 ± 0.216
Q8, Day 56-3.04 ± 0.222-0.78 ± 0.226
Q9, Day 28-0.46 ± 0.260-0.12 ± 0.216
Q9, Day 56-1.96 ± 0.260-0.43 ± 0.269
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.1268 · Adjusted mean difference: -0.46 · 95% CI -1.04 to 0.13
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: -1.75 · 95% CI -2.38 to -1.13
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0245 · Adjusted mean difference: -0.72 · 95% CI -1.35 to -0.09
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: -1.81 · 95% CI -2.44 to -1.18
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.3851 · Adjusted mean difference: -0.29 · 95% CI -0.96 to 0.37
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0002 · Adjusted mean difference: -1.48 · 95% CI -2.22 to -0.73
SecondaryAdjusted Mean Change From Baseline in DHEQ Total Score (Section 2, Q1-34) at Days 28 and 56

The DHEQ was a condition-specific measure of Oral Health-related Quality of Life (OHrQoL) in relation to DH which consisted of a total of 34 questions in section 2 grouped into 5 separate domains: Restrictions(Q1-4), Adaptation(Q5-16), Social Impact(Q17-21), Emotional Impact(Q22-29), and Identity(Q30-34), each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 34 to 238; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in DHEQ Total Score (Section 2, Q1-34) at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-14.79 ± 3.833-7.47 ± 2.678
Day 56-34.56 ± 5.296-8.94 ± 3.394
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.1884 · Adjusted mean difference: -6.19 · 95% CI -15.46 to 3.08
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0002 · Adjusted mean difference: -24.49 · 95% CI -37.00 to -11.97
SecondaryAdjusted Mean Change From Baseline in DHEQ Restrictions Domain (Section 2, Q1-4) Score at Days 28 and 56

Restrictions domain in DHEQ evaluated the ways in which any sensations in teeth affected participant's daily life. This consisted of 4 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 4 to 28; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in DHEQ Restrictions Domain (Section 2, Q1-4) Score at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-2.27 ± 0.634-1.20 ± 0.444
Day 56-4.94 ± 0.742-1.90 ± 0.492
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.3003 · Adjusted mean difference: -0.81 · 95% CI -2.34 to 0.73
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0028 · Adjusted mean difference: -2.77 · 95% CI -4.56 to -0.97
SecondaryAdjusted Mean Change From Baseline in DHEQ Adaptation Domain Score (Section 2, Q5-16) at Days 28 and 56

Adaptation domain in DHEQ evaluated 'the ways in which the sensations in teeth have forced participants to change things in their daily life'; 'things they do in their daily life to avoid experiencing the sensations in their teeth'. This consisted of 12 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 12 to 84; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in DHEQ Adaptation Domain Score (Section 2, Q5-16) at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-6.45 ± 1.600-1.73 ± 1.396
Day 56-12.42 ± 2.530-3.31 ± 1.726
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0784 · Adjusted mean difference: -3.78 · 95% CI -8.00 to 0.44
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0092 · Adjusted mean difference: -8.17 · 95% CI -14.27 to -2.07
SecondaryAdjusted Mean Change From Baseline in DHEQ Social Impact Domain (Section 2, Q17-21) Score at Days 28 and 56

Social Impact domain in DHEQ evaluated the way the sensations affected participants when they were with other people or in certain situations. This consisted of 5 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 5 to 35; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in DHEQ Social Impact Domain (Section 2, Q17-21) Score at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-1.23 ± 0.644-0.94 ± 0.552
Day 56-3.63 ± 0.771-0.24 ± 0.587
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.8686 · Adjusted mean difference: -0.14 · 95% CI -1.82 to 1.54
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0012 · Adjusted mean difference: -3.24 · 95% CI -5.18 to -1.31
SecondaryAdjusted Mean Change From Baseline in DHEQ Emotional Impact Domain (Section 2, Q22-29) Score at Days 28 and 56

Emotional Impact Domain in DHEQ evaluated the way the sensations in participant's teeth made them feel. This consisted of 8 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 8 to 56; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in DHEQ Emotional Impact Domain (Section 2, Q22-29) Score at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-4.10 ± 1.089-3.33 ± 0.957
Day 56-10.23 ± 1.340-2.98 ± 0.958
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.9047 · Adjusted mean difference: -0.17 · 95% CI -3.04 to 2.69
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0001 · Adjusted mean difference: -6.66 · 95% CI -9.95 to -3.38
SecondaryAdjusted Mean Change From Baseline in DHEQ Identity Domain (Section 2, Q30-34) Score at Days 28 and 56

Identity Domain in DHEQ evaluated what the sensations in participant's teeth meant for them. This consisted of 5 questions each scored using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). Thus, the total score ranged from 5 to 35; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in DHEQ Identity Domain (Section 2, Q30-34) Score at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-0.69 ± 0.666-0.27 ± 0.517
Day 56-3.34 ± 0.735-0.51 ± 0.725
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.5733 · Adjusted mean difference: -0.47 · 95% CI -2.14 to 1.19
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0060 · Adjusted mean difference: -2.88 · 95% CI -4.92 to -0.84
SecondaryAdjusted Mean Change From Baseline in Global Oral Health (DHEQ Section 2, Q35) Score at Days 28 and 56

Global Oral Health was evaluated using a single question which asked about the overall health of participant's mouth, teeth, and gums. The scale ranged from 1 (excellent) to 6 (Very poor), where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoints minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Global Oral Health (DHEQ Section 2, Q35) Score at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-0.15 ± 0.076-0.10 ± 0.100
Day 56-0.23 ± 0.082-0.06 ± 0.074
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.2768 · Adjusted mean difference: -0.14 · 95% CI -0.39 to 0.11
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0232 · Adjusted mean difference: -0.26 · 95% CI -0.48 to -0.04
SecondaryAdjusted Mean Change From Baseline in Effect on Life Overall (DHEQ Section 2, Q36-39) Score at Days 28 and 56

Effect on life was evaluated using 4 questions which asked how much the sensations in teeth affected participant's life overall. The scale ranged from 0 (not at all) to 4 (Very much) and thus, the total score ranged from 0 to 16; where the lower score indicated improvement in the symptoms. Change from baseline was calculated as score at indicated post-baseline timepoint minus score at baseline.

Time frame:
Baseline, Day 28 and Day 56
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Effect on Life Overall (DHEQ Section 2, Q36-39) Score at Days 28 and 56
score on a scaleTest ToothpasteReference Toothpaste (Negative Control)
Day 28-0.80 ± 0.253-0.53 ± 0.311
Day 56-1.93 ± 0.277-0.71 ± 0.261
Statistical analysis
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.8996 · Adjusted mean difference: 0.05 · 95% CI -0.75 to 0.85
  • Test Toothpaste vs Reference Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0204 · Adjusted mean difference: -0.90 · 95% CI -1.66 to -0.14

Adverse events

Collected over From signing of informed consent form until 5 days after the last administration of study product or the last study procedure (up to approximately 90 days).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Toothpaste0/53 (0%)0/53 (0%)5/53 (9.4%)
Reference Toothpaste (Negative Control)0/51 (0%)0/51 (0%)4/51 (7.8%)
Most frequent other events
Most frequent other events
EventTest ToothpasteReference Toothpaste (Negative Control)
APHTHOUS ULCERGastrointestinal disorders1/533/51
HYPERAESTHESIA TEETHGastrointestinal disorders1/531/51
GLOSSODYNIAGastrointestinal disorders1/530/51
LIP SWELLINGGastrointestinal disorders1/530/51
ORAL DISORDERGastrointestinal disorders1/530/51
ORAL MUCOSAL EXFOLIATIONGastrointestinal disorders1/530/51
DEHYDRATIONMetabolism and nutrition disorders1/530/51

Baseline characteristics

The Safety population included all randomized participants who received at least one dose of investigational product.

Age, Continuous
Age, Continuous(years)Test ToothpasteReference Toothpaste (Negative Control)Total
Mean49.9 ± 8.2749.9 ± 9.9349.9 ± 9.08
Sex: Female, Male
Sex: Female, Male(Participants)Test ToothpasteReference Toothpaste (Negative Control)Total
Female494392
Male4812
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Test ToothpasteReference Toothpaste (Negative Control)Total
Hispanic or Latino000
Not Hispanic or Latino5351104
Unknown or Not Reported000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Test ToothpasteReference Toothpaste (Negative Control)Total
African American/African Heritage448
American Indian or Alaskan Native101
Asian - South East Asian Heritage101
Native Hawaiian or Other Pacific Islander011
White - Arabic/North African Heritage022
White - White/Caucasian/European Heritage464490
Multiple101
08

Study locations

1 site
  • Salus Research
    Fort Wayne, Indiana 46825, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Anonymized individual participant data and study documents can be requested for further research from ww.clinical-trial-register@haleon.com

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: IPD will be made available within 6 months of publishing the results of the primary endpoints, key secondary endpoints and safety data of the study.

Access criteria: Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension can be granted, when justified, for up to another 12 months.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2024 to primary completion in Jun 2024, 2 months.

Results were first posted in Jun 2025, 1 year after primary completion.

Of 33 industry-sponsored interventional studies with no phase under Dentin Sensitivity, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 6. This study's 2 months is below that.

Counting every sponsor, half of 144 studies reached it within 6 months; a quarter within 3 and three quarters within 10.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2024
First posted
Apr 11, 2024
StartActual
Mar 25, 2024
Primary completionActual
Jun 20, 2024
CompletionActual
Jun 20, 2024
Results first posted
Jun 24, 2025
Last update
Jun 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06359028
Lead sponsor
HALEON
Responsible party
Sponsor
First posted
Apr 11, 2024
Start date
Mar 25, 2024
Primary completion
Jun 20, 2024
Completion
Jun 20, 2024
Results posted
Jun 24, 2025
Last update
Jun 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion